• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Health Tip: Preventing Child Burns

drugsJuly 08, 2019

Tag: Child , burn , prevent

Every day, more than 300 children are treated in emergency rooms for burn-related injuries, says the U.S. Centers for Disease Control and Prevention.

To help prevent your child from being burned, the CDC suggests:

Install and maintain smoke alarms at home.

Supervise children's use of stoves, ovens and microwaves.

Set your water heater's thermostat to under 120 degrees Fahrenheit.

Never leave food unattended on the stove.

Have a fire escape plan.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Previous:How Protect Against Short- and Long-Term Sun Damage

Next:Study finds common cold virus could help kill bladder cancer tumours

Related News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

BioPharmaSpec, the leading global Contract Research Organization (CRO) for Discovery and Preclinical Characterization of Biopharmaceuticals, has officially announced three new European facilities.

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Health Tip: Preventing Child Burns | Pharmasources.com

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may like
More>>

printed children resistant foil

printed children resistant foil

CRN Snap on Nasal Spray Child resistant spray pump with bottle accept customized

CRN Snap on Nasal Spray Child resistant spray pump with bottle accept customized
JRF series coal burning stove

JRF series coal burning stove
Burnet Extract Powder

Burnet Extract Powder
Children

Children
Medecine Bottle 75cc White Vitamin Child Proof Medical Pills Containers With Child Resistant Caps Fo

Medecine Bottle 75cc White Vitamin Child Proof Medical Pills Containers With Child Resistant Caps Fo
Child-Resistant Foil

Child-Resistant Foil
fat burner gummies

fat burner gummies
JRF Series Coal Burnt Hot Air Furnace

JRF Series Coal Burnt Hot Air Furnace
Natural fat burner gummies

Natural fat burner gummies

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service